Editor’s Note: We do not endorse or otherwise have any relationship to companies that produce market analysis and similar reports, but occasionally provide useful information where relevant to the vaccine enterprise and our work in vaccine ethics and policy]

Research and Markets: China Vaccine Industry Report, 2008-2009: Largest Producer in the World with Annual Production of One Billion Person-Portions

“In the past decade, the Chinese vaccine market tripled in scale. China has already become the world’s largest vaccine producer and now has 28 vaccine companies, ranking NO.1 around the globe. It can produce one billion person-portions annually, besides, varieties and quantity it also ranks the top in the world.

“Output of common vaccine reaches 500 million person-portions such as HBV vaccine, measles vaccine, etc. Fully planned immunization has been realized.

“Compared to developed countries, expenses of China on vaccine and diseases treatment are relatively low; therefore, China will attach great importance to vaccine industry development and takes it as the key of healthcare and bio-technology industry.    “The Development Strategy of China Bio-technology Industry has rendered the development of secure new types of vaccines as priority; in the meantime, the Chinese government has employed preferential taxation policy to this industry. In consequence, the vaccine industry will become a high-tech sector with great potential in China’s bio-technology field. It is forecasted that China’s vaccine market scale will approximate RMB8 billion in 2020, with an annual growth rate of 15%, far above world’s level 10%…”

(BUSINESS WIRE, 25 August 2009)